<DOC>
	<DOCNO>NCT00456976</DOCNO>
	<brief_summary>Antipsychotic drug effective treat positive symptom schizophrenia ; however efficacy treat negative symptom limit . This study want evaluate efficacy selegiline augmentation antipsychotic medication treat negative symptom inpatient chronic schizophrenia . With randomized clinical trial two group patient select receive selegiline placebo . Primary end point decrease negative symptom case group . Inclusion criterion : 1- Patients moderate severe negative symptom 2- Patients least one year antipsychotic drug therapy , current dose &gt; = 1 month . 3- No psychotropic drug past month . Exclusion criterion : 1- Severe major depressive disorder , substance abuse , severe positive symptom schizophrenia , Treatment MDD antidepressant drug past month .</brief_summary>
	<brief_title>Efficacy Selegiline Negative Symptoms Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Patients moderate severe negative symptom Patients least one year antipsychotic drug therapy , current dose &gt; = 1 month . No psychotropic drug past month Severe major depressive disorder Substance abuse Severe positive symptom schizophrenia Treatment MDD antidepressant drug past month .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Seligiline</keyword>
	<keyword>Negative symptom</keyword>
	<keyword>Schizopherenia</keyword>
</DOC>